Lupin

2,251.20

-16.50

(-0.73%)

Market Cap

1,02,889.57 Cr

PE Ratio

19.40

Volume

3,68,625.00

Day High - Low

2,286.00 - 2,231.20

52W High-Low

2,494.00 - 1,836.80

compare with

Sun Pharmaceutical

1,791.00 (-0.46%)

Divis Laboratories

6,580.50 (-1.30%)

Torrent Pharmaceuticals

4,364.40 (-1.05%)

Cipla

1,392.70 (-0.59%)

Zydus Life Science

1,093.40 (+1.46%)

Key Fundamentals

Market Cap

1,02,889.57 Cr

EPS

128.45

PE Ratio

19.40

PB Ratio

4.63

Book Value

490.98

EBITDA

7,787.60

Dividend Yield

0.79 %

Industry

Healthcare

Sector

Pharmaceuticals

Return on Equity

19.12

Debt to Equity

0.27

Actual

Company News

View All News

Lupin CFO Eyes Large Specialty Deals With Debt DisciplineToday

Lupin's CFO Swaminathan says the company is targeting significant specialty deals while maintaining a cautious approach to debt and risk management.

Lupin updates on Multicare deal timeline

2 days ago

Lupin's subsidiary Nanomi B.V. is acquiring minority shares in Multicare Pharmaceuticals Philippines. The transaction is now expected to close in July 2026.

Lupin shares Phase 1 data on LNP8701 at ASCO 2026

4 days ago

Lupin announced Phase 1 data for LNP8701 at ASCO 2026, showing safety and stable disease in patients.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,791.00	#1 4,29,720.89	37.54	#1 58,220.10	6.38	#1 11,565	25.80	46.23
Divis Laboratories	6,580.50	1,74,691.60	68.85	10,560.00	8.73	2,520	13.44	50.98
Torrent Pharmaceuticals	4,364.40	1,47,711.13	69.56	13,753.00	19.18	2,028	-26.91	52.33
Cipla	1,392.70	1,12,499.61	29.25	27,711.70	-2.46	3,783	-55.32	59.75
Zydus Life Science	1,093.40	1,10,021.62	21.16	26,719.70	13.65	5,242	7.82	72.44
Dr Reddys Laboratories	1,287.90	1,07,493.67	26.16	33,593.30	-0.44	3,998	-86.05	50.35
Lupin	2,251.20	#7 1,02,889.57	#1 19.40	#5 27,487.50	#2 19.98	#2 5,345	#1 87.72	45.61
Mankind Pharma	2,332.90	96,303.30	50.66	14,277.60	12.03	1,750	31.75	50.18
Aurobindo Pharma	1,422.00	82,589.99	23.73	33,384.70	3.21	3,376	1.99	45.43
Laurus Labs	1,389.10	74,991.48	82.57	6,812.90	#1 21.03	884	21.18	73.71

Automatic Screeners on ScanX

Support 1 Breached

1 Week Low Break

Growth Rate

Revenue Growth

19.98 %

Net Income Growth

61.67 %

Cash Flow Change

-17.77 %

ROE

41.95 %

ROCE

20.69 %

EBITDA Margin (Avg.)

16.64 %

Corporate Action

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
28 Jul 2021	Dividend	₹ 6.50 /share	27 Jul 2021	1,212.25	1,111.60
15 Jul 2022	Dividend	₹ 4.00 /share	14 Jul 2022	683.30	643.20
14 Jul 2023	Dividend	₹ 4.00 /share	14 Jul 2023	732.25	930.75
16 Jul 2024	Dividend	₹ 8.00 /share	16 Jul 2024	1,655.25	1,832.10
02 Aug 2024	Annual General Meeting	NA	02 Aug 2024	1,778.90	1,953.55
07 Nov 2024	Quarterly Result Announcement	NA	07 Nov 2024	2,151.95	2,166.05
11 Feb 2025	Quarterly Result Announcement	NA	11 Feb 2025	2,134.25	2,169.40
14 May 2025	Quarterly Result Announcement	NA	14 May 2025	2,107.70	2,063.00
25 Jul 2025	Dividend	₹ 12.00 /share	25 Jul 2025	2,063.00	1,943.40
05 Aug 2025	Quarterly Result Announcement	NA	05 Aug 2025	1,930.85	1,882.20
11 Aug 2025	Annual General Meeting	NA	11 Aug 2025	1,894.70	1,918.00
06 Nov 2025	Quarterly Result Announcement	NA	06 Nov 2025	1,943.35	1,997.00
12 Feb 2026	Quarterly Result Announcement	NA	12 Feb 2026	2,150.50	2,209.10
07 May 2026	Quarterly Result Announcement	NA	07 May 2026	2,311.50	2,442.90

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
ICICI Prudential Active Momentum Fund Direct-Growth	0.00%	-195905	-2.68%	-2.54%
Sundaram Multi-Factor Fund Direct-Growth	1.47%	60376	1.47%	1.47%
Abakkus Flexi Cap Fund Direct-Growth	2.24%	44000	-0.23%	-0.05%
Capitalmind Flexi Cap Fund Direct-Growth	1.93%	15307	0.67%	1.93%
Bandhan Multi-Factor Fund Direct-Growth	3.92%	12068	-0.06%	1.42%
Bandhan Healthcare Fund Direct-Growth	2.78%	-10000	-1.03%	-0.73%
Samco Mid Cap Fund Direct-Growth	2.72%	8641	2.72%	2.72%
ITI Business Cycle Fund Direct-Growth	0.00%	-7165	-1.79%	0.00%
Groww Multi Asset Allocation Fund Direct-Growth	0.21%	-3269	-0.22%	-0.57%
Unifi Dynamic Asset Allocation Fund Direct-Growth	0.00%	-2125	-0.04%	-0.04%
Tata Nifty Midcap 150 Index Fund Direct-Growth	1.44%	1353	-0.18%	-0.04%
Franklin India Multi-Factor Fund Direct-Growth	1.26%	1231	-0.12%	-0.09%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth	0.51%	933	0.51%	0.51%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth	1.43%	-651	-0.19%	-0.05%
Kotak Active Momentum Fund Direct-Growth	1.60%	494	-0.17%	0.04%
DSP Nifty Healthcare Index Fund Direct-Growth	5.53%	367	-0.29%	-0.03%
UTI Nifty500 Shariah Index Fund Direct-Growth	1.00%	354	-0.08%	0.01%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth	0.51%	334	0.51%	0.51%
Kotak Nifty Midcap 150 Index Fund Direct-Growth	1.45%	276	-0.09%	-0.02%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth	0.72%	245	0.72%	0.72%
JioBlackRock Sector Rotation Fund Direct-Growth	0.39%	196	-0.05%	-0.02%
Nippon India Nifty India Manufacturing Index Fund Direct-Growth	1.44%	111	-0.15%	0.00%
DSP Nifty Midcap 150 Index Fund Direct-Growth	1.43%	85	-0.17%	-0.04%
Groww Nifty Midcap 150 Index Fund Direct-Growth	1.43%	32	-0.20%	-0.04%
Motilal Oswal BSE 1000 Index Fund Direct-Growth	0.28%	27	-0.03%	0.01%

Technical Indicators

RSI(14)

Neutral

45.61

ATR(14)

Less Volatile

52.85

STOCH(9,6)

Neutral

64.45

STOCH RSI(14)

Neutral

48.02

MACD(12,26)

Bearish

-2.28

ADX(14)

Weak Trend

12.26

UO(9)

Bearish

43.39

ROC(12)

Uptrend And Accelerating

0.99

WillR(14)

Neutral

-52.34

About Lupin

Lupin is a global pharmaceutical company producing branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. Founded in 1983, it operates in over 100 markets, specializing in cardiovascular, diabetology, asthma, pediatric, central nervous system, gastrointestinal, anti-infective, and NSAID therapies. Lupin is a leader in anti-TB and cephalosporins segments. The...more

Website

https://www.lupin.com/

Chairperson NameM D Gupta

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Lupin

Company News

Peer Comparison Compare Peers on Screener

Automatic Screeners on ScanX

Corporate Action

Mutual Fund Holdings

Technical Indicators

About Lupin